Physician profile
Amanda Bourne
NPI 1427887629
$2,906.37
in general payments reported to CMS, 2019-2025
17 companies · $1,867 in 2025
The $1,867 reported for 2025 was more than what 92% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,040 · 2025: $1,867.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,906.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,906.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $687.75 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $455.60 | 2024-2025 | |
| Amgen INC. | $391.90 | 2025 | Uplizna |
| Pfizer INC. | $335.00 | 2024-2025 | |
| Emd Serono, INC. | $265.15 | 2025 | Mavenclad |
| Biogen, INC. | $182.70 | 2024-2025 | Vumerity, Tysabri, Avonex |
| Alexion Pharmaceuticals, INC. | $140.32 | 2024-2025 | Ultomiris |
| Tg Therapeutics, INC. | $125.12 | 2024 | |
| Lundbeck LLC | $109.14 | 2024-2025 | Vyepti |
| Genentech USA, INC. | $38.12 | 2024-2025 | Ocrevus Zunovo, Ocrevus |
| Jazz Pharmaceuticals INC. | $37.95 | 2025 | |
| Eisai INC. | $30.09 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $26.38 | 2025 | |
| Axsome Therapeutics, INC. | $26.32 | 2025 | Symbravo |
| Lilly USA, LLC | $25.59 | 2024 | Kisunla |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $14.62 | 2025 | |
| Mdd US Operations, LLC | $14.62 | 2025 | Gocovri |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Bourne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.